<?xml encoding="utf-8" ?> Cytokinetics CYTK reported third-quarter financial results on Wednesday. The transcript from the ...
Ultragenyx Pharmaceutical (NASDAQ: RARE) used its Q3 2026 earnings call to outline two gene therapy launches, major cost ...
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices are ...
Watch Yahoo Finance's streaming coverage for real-time market news, analysis, and expert commentary throughout the day to help you make smarter money decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results